Sun Pharma
- All
- News
- Videos
-
Gautam Adani Emerges As Biggest Dollar Gainer In Forbes Rich List 2024
The collective wealth of Indias 100 richest tycoons surpassed the trillion dollar milestone for the first time as more than 80 per cent of the countrys richest tycoons are now wealthier than they were a year ago
-
Australia's Mayne Pharma Sues India's Sun Pharma Over Patent Infringement
Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.
-
Drug Major Sun Pharma Hit By Ransomware Attack: 5 Facts
Mumbai-based drug major Sun Pharma said on Sunday that a ransomware group has taken responsibility for the March 2 information technology security breach.
-
Sun Pharma Flags Revenue Drop Following 'IT Security Incident' in March: Details
Sun Pharmaceutical Industries on Sunday revealed in a filing that the firm would see a revenue drop in a few of its businesses and incur some expenses due to an "IT security incident" in March. The drugmaker's IT systems were affected by a breach of certain file systems and theft of some company and personal data, while a ransomware group has claim...
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
IIT Kanpur Professor Wins Sun Pharma Science Foundation Research Award
Dr Ateeq is a recipient of the Shanti Swarup Bhatnagar Prize in Medical Sciences (2020). She is also an Elected Fellow of the National Academy of Sciences, India (NASI) and the Indian Academy of Sciences, Bangalore (IASc).
-
3 Indian Firms To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.
-
Sun Pharma Company Launches COVID-19 Drug Favipiravir In India
Sun Pharmaceutical Industries has said it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
-
PSU Banks Drag Markets; Sensex Slumps 430 Points To Close At 33,317 Level, Nifty Settles Below 10,250
The top drags in the Sensex pack were Sun Pharma, State Bank of India, ICICI Bank, Mahindra & Mahindra and Maruti Suzuki.
-
Sun Pharma Stock In Focus After Q3 Profit Falls 75%
Motilal Oswal maintains 'buy' rating on Sun Pharma Stock, while Edelweiss downgrades the scrip rating to 'Hold' from 'Buy'
-
Sun Pharma Q3 Profit Slides 75% To Rs 365 Crore, Misses Estimates
Total revenue from operations fell 16 per cent to 66.53 billion rupees.
-
Sensex Extends Record Run, Nifty Hits 10,550
Sun Pharma, Tech Mahindra, Aurobindo Pharma, Dr Reddy's and Vedanta were among the top gainers on the Nifty 50.
-
Sensex Closes Down 106 Points, Nifty Sheds 0.28%, Airtel, Infosys, Tata Motors Biggest Losers
Sensex closed106 points, 0.31%, lower to 33,619, Nifty shed29 points, or 0.28%, to close at 10,370 points.
-
Sensex, Nifty Close Flat, Infosys, RIL, Sun Pharma Top Gainers
Senex, Nifty on Thursday closed on a flat-to-positive note as investors traded with caution on the back of weak global cues
-
Gautam Adani Emerges As Biggest Dollar Gainer In Forbes Rich List 2024
The collective wealth of Indias 100 richest tycoons surpassed the trillion dollar milestone for the first time as more than 80 per cent of the countrys richest tycoons are now wealthier than they were a year ago
-
Australia's Mayne Pharma Sues India's Sun Pharma Over Patent Infringement
Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.
-
Drug Major Sun Pharma Hit By Ransomware Attack: 5 Facts
Mumbai-based drug major Sun Pharma said on Sunday that a ransomware group has taken responsibility for the March 2 information technology security breach.
-
Sun Pharma Flags Revenue Drop Following 'IT Security Incident' in March: Details
Sun Pharmaceutical Industries on Sunday revealed in a filing that the firm would see a revenue drop in a few of its businesses and incur some expenses due to an "IT security incident" in March. The drugmaker's IT systems were affected by a breach of certain file systems and theft of some company and personal data, while a ransomware group has claim...
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
IIT Kanpur Professor Wins Sun Pharma Science Foundation Research Award
Dr Ateeq is a recipient of the Shanti Swarup Bhatnagar Prize in Medical Sciences (2020). She is also an Elected Fellow of the National Academy of Sciences, India (NASI) and the Indian Academy of Sciences, Bangalore (IASc).
-
3 Indian Firms To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.
-
Sun Pharma Company Launches COVID-19 Drug Favipiravir In India
Sun Pharmaceutical Industries has said it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
-
PSU Banks Drag Markets; Sensex Slumps 430 Points To Close At 33,317 Level, Nifty Settles Below 10,250
The top drags in the Sensex pack were Sun Pharma, State Bank of India, ICICI Bank, Mahindra & Mahindra and Maruti Suzuki.
-
Sun Pharma Stock In Focus After Q3 Profit Falls 75%
Motilal Oswal maintains 'buy' rating on Sun Pharma Stock, while Edelweiss downgrades the scrip rating to 'Hold' from 'Buy'
-
Sun Pharma Q3 Profit Slides 75% To Rs 365 Crore, Misses Estimates
Total revenue from operations fell 16 per cent to 66.53 billion rupees.
-
Sensex Extends Record Run, Nifty Hits 10,550
Sun Pharma, Tech Mahindra, Aurobindo Pharma, Dr Reddy's and Vedanta were among the top gainers on the Nifty 50.
-
Sensex Closes Down 106 Points, Nifty Sheds 0.28%, Airtel, Infosys, Tata Motors Biggest Losers
Sensex closed106 points, 0.31%, lower to 33,619, Nifty shed29 points, or 0.28%, to close at 10,370 points.
-
Sensex, Nifty Close Flat, Infosys, RIL, Sun Pharma Top Gainers
Senex, Nifty on Thursday closed on a flat-to-positive note as investors traded with caution on the back of weak global cues
